I
INBX
Inhibrx Biosciences Inc
81.55
-3.45-4.06%After Hours: 80.99 -0.56 -0.69%19:34 07/24 EDT
OPEN/PREV CLOSE86.00/85.00
TODAY RANGE81.54-86.00
VOL164.94K
MARKET CAP1.20B
52 WEEK RANGE20.55-155.29
AVG VOL (3M)401.81K
% TURNOVER1.12%
TURNOVER--
P/E (TTM)-9.7204
% RANGE5.25%
EPS(TTM)-8.3896
P/E(FORWARD)-8.4029
P/B-56.6319
BVPS-1.4400
DIVIDEND--
P/S914.24
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP801.73M
SHARES OUTSTANDING14.67M
NEXT EARNINGS08/11-08/17
FREE FLOAT9.83M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Does Inhibrx Biosciences' (INBX) Expanded Credit Facility Quietly Redefine Its Risk‑Reward Profile?
Seeking Alpha·07/17 10:43
Inhibrx Biosciences: The Rare Disease Launch Is Only The Opening Act
TipRanks·07/17 09:17
Inhibrx Biosciences Expands Credit Facility to $500 Million
Simply Wall St·07/10 15:44
Does Inhibrx Biosciences' (INBX) Shift Into Russell Growth Indexes Reframe Its Core Investment Story?
Simply Wall St·07/08 08:28
Inhibrx Biosciences (INBX) Following Russell Reshuffle With Valuation Still Hard To Pin Down
TipRanks·07/07 19:55
Citizens healthcare analysts hold an analyst/industry conference call
Simply Wall St·07/02 23:33
How Russell Index Reclassification Toward Growth Benchmarks Will Impact Inhibrx Biosciences (INBX) Investors
Simply Wall St·06/27 10:16
Inhibrx Biosciences (INBX) Wins FDA Filing Acceptance, Is More Upside Already Priced In?
Seeking Alpha·06/24 12:01
10 small-cap U.S. healthcare stocks with the strongest momentum grades
Simply Wall St·06/23 20:25
The Bull Case For Inhibrx Biosciences (INBX) Could Change Following FDA BLA Acceptance For Ozekibart
Simply Wall St·06/20 03:35
Inhibrx Biosciences (INBX) Stock Near Analyst Target After FDA Filing for Ozekibart
Simply Wall St·06/16 05:24
How FDA’s Ozekibart BLA Acceptance for Chondrosarcoma Could Shape Inhibrx Biosciences (INBX) Investors
Same Industry
Name/Symbol
Change%
Price